04.01.02
BotanicLab Responds To
SPES, PC SPES Recall
Two supplements manufactured by BotanicLab, Brea, CA, were voluntarily recalled in February when the California Department of Health Services (DHS) found its SPES product to contain alprazolam (also known as Xanax) and its other product, PC SPES, to contain warfarin (generic name for Coumadin, a synthetic blood thinner). According to a statement from the company, BotanicLab is extremely concerned about the discovery of contaminants in SPES, claiming it never knowingly included any synthetic substance as an ingredient formulated in the composition of its products. While BotanicLab is aggressively investigating the issue, it believes the contamination occurred in China with its raw material suppliers and has since imposed more rigorous controls in its supply chain review process. In relation to PC SPES, the company said independent lab results reported the material was not necessarily warfarin, but may instead be a phytocoumarin (a compound naturally synthesized in various green plants) that may mimic warfarin in laboratory testing. The company is undertaking additional testing of PC SPES in both commercial and academic laboratories to gain more insight into how to settle the question of whether the material at issue is synthetic or natural. BotanicLab intends to share the results of these tests with DHS as well as with customers as soon as they are available.
SPES, PC SPES Recall
Two supplements manufactured by BotanicLab, Brea, CA, were voluntarily recalled in February when the California Department of Health Services (DHS) found its SPES product to contain alprazolam (also known as Xanax) and its other product, PC SPES, to contain warfarin (generic name for Coumadin, a synthetic blood thinner). According to a statement from the company, BotanicLab is extremely concerned about the discovery of contaminants in SPES, claiming it never knowingly included any synthetic substance as an ingredient formulated in the composition of its products. While BotanicLab is aggressively investigating the issue, it believes the contamination occurred in China with its raw material suppliers and has since imposed more rigorous controls in its supply chain review process. In relation to PC SPES, the company said independent lab results reported the material was not necessarily warfarin, but may instead be a phytocoumarin (a compound naturally synthesized in various green plants) that may mimic warfarin in laboratory testing. The company is undertaking additional testing of PC SPES in both commercial and academic laboratories to gain more insight into how to settle the question of whether the material at issue is synthetic or natural. BotanicLab intends to share the results of these tests with DHS as well as with customers as soon as they are available.